Studies of beneficial interactions between active medicaments and excipients in pharmaceutical formulations

International Journal of Pharmaceutics

Volumn 187, Issue 1, 1999, Pages 1-15

  Kalinkova, G N ^a  

^a Laboratory of Infrared Spectroscopy   (Bulgaria)

Author keywords

Active medicaments; Bioavailability; Crystalline structures; Excipients; Infrared spectroscopy; Interactions; Pharmaceutical formulations; Therapeutic activity; X ray diffraction patterns

Indexed keywords

AMOXICILLIN; ANALGESIC AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CALCIUM PHOSPHATE DIBASIC; CELLULOSE DERIVATIVE; CHITOSAN; CHLORAMBUCIL; COPOLYMER; CORTICOSTEROID; CYCLODEXTRIN; EXCIPIENT; HYDROCORTISONE; IBUPROFEN; INDOMETACIN; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; OMEPRAZOLE; PECTIN; POLYMER; RADIOPROTECTIVE AGENT; SILICON DIOXIDE; TOLBUTAMIDE; TRANQUILIZER; UNINDEXED DRUG;

COMPLEX FORMATION; DISSOLUTION; DOG; DRUG FORMULATION; DRUG INTERACTION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; HUMAN; HYDROGEN BOND; INFRARED SPECTROSCOPY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; X RAY DIFFRACTION;

EID: 0032869007     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00176-3     Document Type: Article

References (58)

1. Adeyeye C.M., Rowley J., Madu D., Javadi M., Sabnis S.S. Evaluation of crystallinity and drug release stability of directly compressed theophylline hydrophilic matrix tablets stored under varied moisture conditions. Int. J. Pharm. 116:1995;65-75.
2. Ahlneck C., Zografi G. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state (Review). Int. J. Pharm. 62:1990;87-95.
3. Ammar H.O., El-Nahhas S.A. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 1. Allopurinol. Pharmazie. 50(1):1995;49-51.
4. Ammar H.O., El-Nahhas S.A. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 2. Colchicine. Pharmazie. 50(4):1995;269-272.
5. Ammar H.O., El-Nahhas S.A. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 3. Bromhexine hydrocloride. Pharmazie. 50(6):1995;408-410.
6. Ammar H.O., Ghorab M., El-Nahhas S.A., Omar S.M., Ghorab M.M. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 4. Chlorpromazine hydrochloride. Pharmazie. 50(12):1995;805-808.
7. Bekers O., Beijnen J.H., Kempers Y.A.G., Bult A., Underberg W.J.M. Effects of cyclodextrins on N-trifluoroacetyldoxorubicin-14-valerate (AD-32) stability and solubility in aqueous media. Int. J. Pharm. 68:1991;271-276.
8. Büyüktimkin S., Büyüktimkin N., Rytting J.H. Interaction of indomethacin with a new penetration enhancer, dodecyl 2-(N,N-dimethylamino) propionate (DDAIP): its effect on transdermal delivery. Int. J. Pharm. 127:1996;245-253.
9. Cserháti T. Interaction of some anticancer drugs with carboxymethyl-β-Cyclodextrin. Int. J. Pharm. 124:1995;205-211.
10. Czejka M., Schuller J., Schernhammer E., Bandak S. Arzneistoff-Interaktion zwischen Interferon-2b und 5-Fluorouracil wahrend funftagiger itravenozer 5FU-Infusion. Pharmazie. 50(6):1995;416-419.
11. De Taeye J., Zeegers-Huyskens T. Infrared study of the interaction between caffeine and hydroxylic derivatives. J. Pharm. Sci. 74(6):1985;660-663.
12. Dibner M.D. The pharmaceutical industry: impacts of biotechnology. Trends in Pharmacol. Sci. 6(9):1985;343-346.
13. Ek R., Wormald P., Östelius J., Iversen T., Nyström C. Crystallinity index of microcrystalline cellulose particles compressed into tablets. Int. J. Pharm. 125:1995;257-264.
14. El-Monem A., Foda, Said S. Effect of complexation of indometacin with calcium gliycerophosphate on its bioavailability, ulcerogenicity and antiinflammatory activity in rats. Pharm. Ind. 53(1):1991;94-97.
15. Forni F., Coppi G., Iannuccelli V., Vandelli M.A., Cameroni R. The grinding of the polymorphic forms of chlorapmhenicol stearic ester in the presence of colloidal silica. Acta Pharm. Suec. 25:1988;173-180.
16. Gasheva L.M., Kalinkova G., Minkov E., Krestev V. IR spectroscopic investigations of amoxicillin trihydrate included in the technological models sirup granules in ethylcellulose. J. Mol. Struct. 115:1984;323-326.
17. Giordano F., Gazzaniga A., Bettinetti G.P., La Manna A. The influence of water content on the binding capacity of β-cyclodextrin. Int. J. Pharm. 62:1990;153-156.
18. Green A.R., Miller E.S., Guillory J.K. Physical properties of the complexes formed between heptakis (2,6-di-O-methyl)-β-cyclodextrin, β-Cyclodextrin, and chlorambucil. J. Pharm. Sci. 80(2):1991;186-189.
19. Griesser U.J., Burger A. The effect of water vapor pressure on desolvation kinetics of caffeine 4/5-hydrate. Int. J. Pharm. 120:1995;83-93.
20. Guyot M., Fawaz F., Bildet J., Bonini F., Lagueny A.-M. Physicochemical characterization and dissolution of norfloxacin/cyclodextrin inclusion compounds and PEG solid dispersions. Int. J. Pharm. 123:1995;53-63.
21. Holgado M.A., Fernandez-Arevalo M., Alvarez-Fuentes J., Caraballo I., Llera J.M., Rabasco A.M. Physical characterization of carteolol: Eudragit L binding interaction. Int. J. Pharm. 114:1995;13-21.
22. Hosny E.A., Al-Angary A.A. Bioavailability of sustained release indomethacin suppositories containing polycarbophil. Int. J. Pharm. 113:1995;209-213.
23. Imai T., Shiraishi S., Saito H., Otagiri M. Interaction of indomethacin with low molecular weight chitosan, and improvements of some pharmaceutical properties of indomethacin by low molecular weight chitosans. Int. J. Pharm. 67:1991;11-20.
24. Kalinkova, G., Krasteva, S., 1989. IR-spectroscopic investigation of interactions in the drug preparation Nystatin-plaque. In: Jordanov B., Kirov, N., Simova, P. (Eds.) Recent Developments in Molecular Spectroscopy, Proc. Tenth Nat. Conf. Molec. Spectr. Int. Particip., Blagoevgrad, Bulgaria, 29. VIII.-3.IX. 1988, World Scientific, Singapore, 705-709.
25. Kawashima Y., Lin S.Y., Takenaka H. Polymorphism and drug release behaviour of spray-dried microcapsules of sulfamethaxazole with polysaccharide gum and colloidal silica. Drug Develop. Ind. Pharm. 9(8):1983;1445-1463.
26. Kawashima Y. Spherical crystallization and pharmaceutical systems. Pharm. Inter. 5(2):1984;40-43.
27. Kawashima Y., Lin S.Y., Ogawa M., Handa T., Takenaka H. Preparations of agglomerated crystals of polymorphic mixtures and a new complex of Indomethacin-Epirizole by the spherical crystallization technique. J. Pharm. Sci. 74(11):1985;1152-1156.
28. Kedzierewicz F., Hoffman M., Maincent P. Comparison of tolbutamide β-cyclodextrin inclusion compounds and solid dispersions, physicochemical characteristics and dissolution studies. Int. J. Pharm. 58:1990;221-227.
29. Kedzierewicz F., Villieras F., Zinutti C., Hoffman M., Maincent P. A 3 year stability study of tolbutamide solid dispersions and β-cyclodextrin complex. Int. J. Pharm. 117:1995;247-251.
30. Kidani Y., Asano Y., Noji M. Synthesis of platinum(II) complexes of 4-substituted O-phenylenediamine derivatives and determination of their antitumor activity. Chem. Pharm. Bull. 11:1979;2577-2588.
31. Kochhar S.K., Rubinstein M.H., Barnes D. The effects of slugging and recompression on pharmaceutical excipients. Int. J. Pharm. 115:1995;35-43.
32. Kubinyi H. Strategies and recent technologies in drug discovery (Review). Pharmazie. 50(10):1995;647-662.
33. Landin M., Casalderrey M., Martynez-Pacheco R., Gomez-Amoza J.L., Souto C., Concheiro A., Rowe R.C. Chemical stability of acetylsalicylic acid in tablets prepared with different particle size fractions of a commercial brand of dicalcium phosphate dihydrate. Int. J. Pharm. 123:1995;143-144.
34. Lee, Hyuk-Koo, Hajdu J., McGoff P. Propranolol: methacrylic acid copolymer binding interaction. J. Pharm. Sci. 80(2):1991;178-180.
35. Louden J.D., Rowe R.C. A quantitative examination of the structure of emulsions prepared using cetostearyl alcohol and cetrimide using Fourier transform infrared microscopy. Int. J. Pharm. 63:1990;219-225.
36. Müller B.W. The pseudopolymorphism of magnesium stearate. Zbl. Pharm. 116:1977;1261-1266.
37. Nakai Y. Molecular behavior of medicinals in ground mixtures with microcrystalline cellulose and cyclodextrins. Drug Dev. Ind. Pharm. 12(7):1986;1017-1039.
38. Neubert R., Fritsch B., Dongowski G. Interactions between food components and drugs, part 3: interactions between pectin and propranolol. Pharmazie. 50(6):1995;414-416.
39. Nokhodchi A., Rubinstein M.H., Larhrib H., Guyot J.C. The effect of moisture content on the energies involved in the compaction of ibuprofen. Int. J. Pharm. 120:1995;13-20.
40. Oguchi T., Okada M., Yonemochi E., Yamamoto K., Nakai Y. Freeze-drying of drug-additive binary systems. III. Crystallization of α-cyclodextrin inclusion complex in freezing process. Int. J. Pharm. 61:1990;27-34.
41. Oguchi T., Matsumoto K., Yonemochi E., Nakai Y., Yamamoto K. Dissolution studies in organic solvents for evaluating hydrogen-bond matrix of cellulose in the ground mixture. Int. J. Pharm. 113:1995;97-102.
42. Peters H., Unger E., Moll F. FTIR-ATR-Identifizierung der Hilfstoffe von Arzneizubereitungen. Pharmazie. 50(1):1995;43-48.
43. Preiss A., Mehnert W., Fromming K.-H. Penetration of hydrocortisone into excised human skin under the influence of cyclodextrins. Pharmazie. 50(2):1995;121-126.
44. Rachnev N., Kalinkova G., Toneva-Balucheva R., Krestev V. Some investigations of interactions between dextrans-promethazine hydrochloride and pectins-promethazine hydrochloride. Pharmacia. 36(5):1986;20-25.
45. Ratajczak H., Orville-Thomas W.S. Molecular Interactions. 1984;598 Mir, Moscow.
46. Sigurardottir A.M., Loftsson T. The effect of polyvinylpyrrolidone on cyclodextrin complexation of hydrocortisone and its diffusion through hairless mouse skin. Int. J. Pharm. 126:1995;73-78.
47. Singla A.K., Wadhwa H. Zinc-indomethacin complex: synthesis, physicochemical and biological evaluation in the rat. Int. J. Pharm. 120:1995;145-155.
48. Takahashi Y., Nakashima K., Ishihara T., Nakagawa H., Sugimoto I. Polymorphism of fostedil: characterization and polymorphic change by mechanical treatmens. Drug Dev. Ind. Pharm. 11(8):1985;1543-1563.
49. Takahashi T., Takayama K., Machida Y., Nagai T. Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate. Int. J. Pharm. 61:1990;35-41.
50. Tirkkonen S., Urtti A., Paronen P. Buffer controlled release of indomethacin from ethylcellulose microcapsules. Int. J. Pharm. 124:1995;219-229.
51. Torrado-Santiago A., Torrado J.J., Cadorniga R. Effect of different excipients on release characteristics of acetylsalicylic acid from compressed pellets. Pharmazie. 50(7):1995;476-478.
52. Torrado-Santiago, Torrado S., Agis A., Jimenez M.E., Cadorniga R. Effect of dissolution profile and (-)-α-bisabolol on the gastrotoxicity of acetylsalicylic acid. Pharmazie. 50(2):1995;141-143.
53. Tsunematsu H., Ishida E., Yoshida S., Yamamoto M. Synthesis and enzymatic hydrolysis of aspirin-basic aminoacid ethyl esters. Int. J. Pharm. 68:1991;77-86.
54. Valentova J., Gombosova I., Zemlicka M., Laginova V., Svec P. Radioprotective activity of N-Salicylideneaminoalkanoatocopper (II) complexes. Pharmazie. 50(6):1995;442-443.
55. Vandelli M.A., Salvioli G., Mucci A., Panini R., Malmusi L., Forni F. 2-Hydroxypropyl-β-cyclodextrin complexation with ursodeoxycholic acid. Int. J. Pharm. 118:1995;77-83.
56. Veiga F., Teixeira-Dias J.J.C., Kedzierewicz F., Sousa A., Maincent P. Inclusion complexation of tolbutamide with β-cyclodextrin and hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 129:1996;63-71.
57. Wolf B., Finke I., Schmitz W. Einsatz der perlcellulose zur kontrollierten Arzneistoff-Freigabe. Pharmazie. 51(2):1996;104-112.
58. Zeng X.M., Martin G.P., Marriott C. The controlled delivery of drugs to the lung (Review). Int. J. Pharm. 124:1995;149-164.